
Overview
Roby A. Thomas, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Thomas is trained in the management of all cancers and blood disorders with a focus in genitourinary and gastrointestinal malignancies.
Dr. Thomas is highly rated in 26 conditions, according to our data. His top areas of expertise are Prostate Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Gamma Knife Radiosurgery, and Endoscopy.
His clinical research consists of co-authoring 21 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UPMC Hillman Cancer Center
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is highly rated in 42 conditions, according to our data. Her top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery.
UPMC Hillman Cancer Center
Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is highly rated in 13 conditions, according to our data. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).
UPMC Hillman Cancer Center
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center.Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is highly rated in 14 conditions, according to our data. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy.
Frequently Asked Questions about Dr. Roby Thomas
How do I make an appointment with Dr. Roby Thomas?
You can book an appointment with Dr. Roby Thomas by calling their office at 412-438-2551. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Roby Thomas a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Roby Thomas is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Roby Thomas specialize in?
While Dr. Roby Thomas is a Hematology Oncology, they have specific expertise in Prostate Cancer, Pancreatic Cancer, and Familial Pancreatic Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Roby Thomas participate in research or clinical trials?
Yes. Dr. Roby Thomas has published 21 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Roby Thomas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Roby Thomas accept my insurance?
Dr. Roby Thomas accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 412-438-2551 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Pancreatic CancerDr. Thomas isDistinguished. Learn about Pancreatic Cancer.
- Prostate CancerDr. Thomas isDistinguished. Learn about Prostate Cancer.
- Advanced
- Adult Soft Tissue SarcomaDr. Thomas isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Appendix CancerDr. Thomas isAdvanced. Learn about Appendix Cancer.
- Bone TumorDr. Thomas isAdvanced. Learn about Bone Tumor.
- Chromophobe Renal Cell CarcinomaDr. Thomas isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Thomas isAdvanced. Learn about Clear Cell Sarcoma.
- Epithelioid SarcomaDr. Thomas isAdvanced. Learn about Epithelioid Sarcoma.
- Experienced
- AgranulocytosisDr. Thomas isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Thomas isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Alveolar Soft Part SarcomaDr. Thomas isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Ampullary CancerDr. Thomas isExperienced. Learn about Ampullary Cancer.
- AstrocytomaDr. Thomas isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Thomas isExperienced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).



